Search
Search Results
##search.searchResults.foundPlural##
-
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1228PDF: 1140HTML: 422 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4538PDF: 2731HTML: 2245 -
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277541PDF: 1751HTML: 3837 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
774PDF: 908Suppl. Files: 112HTML: 62 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3174PDF: 1485HTML: 394 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
8862PDF: 5956HTML: 87459Fig.1b: 164Fig.1c: 165Fig.2a: 156Fig.2b: 161Fig.4: 169Fig.2c: 158Fig.3: 163Tab.1: 212Tab.2: 191Tab.3: 177Tab.4: 198Fig1a: 158 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1545PDF: 1134HTML: 184 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2434PDF: 817HTML: 8788Efremov 1: 205Efremov 2: 165 -
Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy
2713PDF: 728HTML: 1243Blood Count trend before and during lenalidomide treatment: 154Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 169 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
3828PDF: 1440HTML: 9171Untitled: 258Untitled: 163Untitled: 149Untitled: 145Untitled: 163Untitled: 316 -
DISTRIBUTION OF DIFFERENT PML/RAR? BCR ISOFORMS IN INDIAN ACUTE PROMYELOCYTIC LEUKAEMIA (APL) PATIENTS AND CLINICOHEMATOLOGICAL CORRELATION
1404PDF: 869HTML: 2193Response to reviewers comments: 157 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1537PDF: 768HTML: 840jdoe, table 2 infections CML .doc: 174jdoe, table 1 infections CML .doc: 161 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
2749PDF: 1192HTML: 2666Figure 1: 147 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2174PDF: 829HTML: 2063 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1541PDF: 1039HTML: 99 -
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
2833PDF: 1064HTML: 3018 -
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1484PDF: 875HTML: 1934Figure: 150Tables: 166ALL revision 1: 174response to reviewer: 159 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3157PDF: 1300HTML: 4104 -
DNA Repair Genes and Chronic Myeloid Leukemia: XPD (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (1394) Gene Polymorphisms Polymorphisms of DNA Repair Genes in CML
1036PDF: 384HTML: 218 -
Osteolytic bone lesions – A rare presentation of AML M6.
1925PDF: 1052HTML: 7899Untitled: 186 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1237PDF: 531Suppl. Files: 326HTML: 128 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1134PDF: 724HTML: 1331Figure 1: 160Figure 2: 159 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3229PDF: 1430HTML: 3975
1 - 43 of 43 items







